GLP-1 & compounded medication availability in Texas (2026)

Texas is one of the most straightforward states in the country for telehealth-prescribed compounded medications, and the one state where OrderlyMeds has in-state fulfillment, through Casa pharmacy in Stafford, TX. Here is exactly what ships to Texas addresses across all ten product lines we track, and what the state’s pharmacy regulators actually say.

Baseline state

Availability facts last reviewed: November 16, 2026

What ships to Texas: all ten lines

Availability of all ten OrderlyMeds product lines in Texas, with typical delivery times and notes
Product lineAvailable in Texas?Typical deliveryNotes
GLP-1 (compounded semaglutide) Yes 8–10 business days In-state fulfillment via Casa pharmacy (Stafford, TX).
GLP-1/GIP (compounded tirzepatide) Yes 8–10 business days Flat national price at every dose.
NAD+ Yes 8–10 business days Ships from licensed partner pharmacies.
Sermorelin Yes 8–10 business days Longevity family; same ordering flow.
Glutathione No N/A Not in the OrderlyMeds formulary today.
BPC-157 Yes 8–10 business days Carried as a compounded injectable. Federal status below.
TB-500 Yes 8–10 business days Carried as a compounded injectable; see its section below.
KPV No N/A Not carried, since we compound these lines as injectables only.
Epitalon Yes 8–10 business days Carried as a compounded injectable; federal picture below.
MOTS-c Yes 8–10 business days Carried as a compounded injectable; its federal record is its own, below.

A “No” row means exactly that. We would rather show you an honest gap than a padded catalog. Texas facts on this page were last reviewed on November 16, 2026.

Research peptides in Texas: BPC-157, TB-500, KPV, Epitalon & MOTS-c

Four of these five are part of the OrderlyMeds formulary today, in Texas and in every state we serve: BPC-157, TB-500, Epitalon and MOTS-c, each compounded as an injectable. KPV is not, because we compound these lines as injectables only. Each section below states that line’s own federal record, its FDA safety position and its compounding pathway, which are not identical from one peptide to the next, and it states them whether or not the line ships to you, because availability questions about these peptides deserve real answers, not marketing.

BPC-157 in Texas

Carried by OrderlyMeds for Texas addresses as a compounded injectable, filled under a patient-specific prescription. The two federal facts below apply to it in full.

FDA’s evaluation of bulk drug substances for compounding under section 503A placed BPC-157 in Category 2, and BPC-157 has no FDA-approved indication. Under the enforcement-discretion policy HHS announced October 27–29, 2026, state-licensed 503A pharmacies may lawfully compound and dispense BPC-157 pursuant to a valid patient-specific prescription while FDA’s final rulemaking on its bulks-list status is pending. Sources: FDA — 503A bulk drug substances (Category 2) · HHS — peptide compounding enforcement-discretion policy (Oct 2026).

TB-500 in Texas

Part of our Texas offering as a compounded injectable, dispensed under a patient-specific prescription. Read the two federal facts below before you order.

FDA’s evaluation of bulk drug substances for compounding under section 503A placed TB-500 (thymosin beta-4 fragment) in Category 2, and TB-500 (thymosin beta-4 fragment) has no FDA-approved indication. Under the enforcement-discretion policy HHS announced October 27–29, 2026, state-licensed 503A pharmacies may lawfully compound and dispense TB-500 pursuant to a valid patient-specific prescription while FDA’s final rulemaking on its bulks-list status is pending. Sources: FDA — 503A bulk drug substances (Category 2) · HHS — peptide compounding enforcement-discretion policy (Oct 2026).

KPV in Texas

We do not ship KPV to Texas, or to any state. Our peptide lines are compounded as injectables, and KPV is not one of them.

FDA’s evaluation of bulk drug substances for compounding under section 503A placed KPV in Category 2, and KPV has no FDA-approved indication. Under the enforcement-discretion policy HHS announced October 27–29, 2026, state-licensed 503A pharmacies may lawfully compound and dispense KPV pursuant to a valid patient-specific prescription while FDA’s final rulemaking on its bulks-list status is pending. Sources: FDA — 503A bulk drug substances (Category 2) · HHS — peptide compounding enforcement-discretion policy (Oct 2026).

Epitalon in Texas

Epitalon is in our formulary for Texas as a compounded injectable, under a patient-specific prescription. The federal facts below apply unchanged.

FDA’s evaluation of bulk drug substances for compounding under section 503A placed Epitalon in Category 2, and Epitalon has no FDA-approved indication. Under the enforcement-discretion policy HHS announced October 27–29, 2026, state-licensed 503A pharmacies may lawfully compound and dispense Epitalon pursuant to a valid patient-specific prescription while FDA’s final rulemaking on its bulks-list status is pending. Sources: FDA — 503A bulk drug substances (Category 2) · HHS — peptide compounding enforcement-discretion policy (Oct 2026).

MOTS-c in Texas

MOTS-c ships to Texas addresses as a compounded injectable, filled on a patient-specific prescription. Read its federal record below on its own terms, because it is not the wording the four lines above carry.

FDA has evaluated MOTS-c as a bulk drug substance nominated for the section 503A bulks list and proposed that neither MOTS-c (free base) nor MOTS-c acetate be included on it, and MOTS-c has no FDA-approved indication. MOTS-c was formerly listed in Category 2 of FDA’s interim compounding policy, and it is no longer on that active list as of FDA’s April 22, 2026 update, because the nomination was withdrawn by the nominator. FDA’s record for the substance notes a potential immunogenicity concern by certain routes and no clinical data in humans, and FDA presented MOTS-c to its Pharmacy Compounding Advisory Committee in July 2026. Under the enforcement-discretion policy HHS published October 30, 2026 at 91 FR 68526, HHS does not intend to act against a state-licensed pharmacy, Federal facility, or licensed physician compounding MOTS-c under section 503A, limited to subcutaneous or intramuscular administration, under a valid patient-specific prescription, and subject to the policy’s other conditions, while rulemaking on the bulks list is pending. That policy does not add MOTS-c to the bulks list and does not make it an FDA-approved drug. Sources: FDA — bulk drug substances that may present significant safety risks (Category 2 and withdrawn nominations) · FDA — PCAC briefing document, July 23–24, 2026 (MOTS-c proposals, points 7–8) · HHS — 91 FR 68526, enforcement-discretion policy for 503A peptide compounding.

What Texas’s pharmacy regulators say about compounded medications

Texas takes a licensure-first approach: the state focuses on who may compound and dispense rather than singling out medication categories. For a Texas patient ordering through telehealth, the questions that matter are whether the prescriber holds a Texas license, whether the pharmacy is licensed for Texas, and whether the prescription is written for you specifically. None of the ten lines on this page carries a Texas-specific restriction beyond those baseline requirements.

Texas regulates pharmacy compounding through standard Pharmacy Act licensure and board rules; no peptide-specific or GLP-1-specific prohibition has been published by the board. Source: Texas State Board of Pharmacy.

Out-of-state pharmacies shipping prescriptions to Texas patients must hold a Texas nonresident (Class E) pharmacy license from the board. Source: Texas State Board of Pharmacy.

Texas permits prescriptions issued on the basis of a valid telemedicine encounter; a prior in-person visit is not required where the standard of care is met. Source: Center for Connected Health Policy (CCHP) Policy Finder.

In practice, a Texas order follows the same path as any other OrderlyMeds order: an online eligibility check, an evaluation by a Texas-licensed provider, and fulfillment by a licensed partner pharmacy. Because Casa pharmacy operates inside the state, Texas orders are among the few in the country that can be filled without crossing a state line at all. Pricing is national, so the price on our pricing page is the Texas price, at every dose.

Texas availability FAQs

Is compounded semaglutide available in Texas?

Yes. OrderlyMeds ships compounded semaglutide to Texas addresses, with in-state fulfillment available through Casa pharmacy in Stafford, TX. New customers start at $74/month for the first two months.

Do I need to see a doctor in person to get started in Texas?

No in-person visit is needed. A telemedicine evaluation by a Texas-licensed provider is how OrderlyMeds works in every state, and the regulator section above carries the cited detail.

Can I get BPC-157 or other research peptides shipped to Texas?

Four of the five: BPC-157, TB-500, Epitalon and MOTS-c ship to Texas addresses as compounded injectables, under a patient-specific prescription. KPV does not, because we compound these lines as injectables only. The sections above state each one’s own current federal status, including the FDA safety position that applies regardless of where you buy.

How long does delivery to Texas take?

Our published window is 8–10 business days from signup, and Texas orders filled in-state often beat it.

Keep exploring

Ready when you are

See if you’re eligible

Compounded semaglutide from $74/month for your first 2 months — provider visit, medication, syringes, and shipping all included, at the same price for every dose. No membership fees.

Check eligibility

Secure. Private. No commitment

The OrderlyMeds eligibility check on a phone